E-drug: parallel imports
-------------------------------------------------
Liberation, a french newspaper, publishes an article about parallel imports
of pharmaceuticals in Europe.
According to Jacques Pichot, Sanofi, parallel import amounts are less than
FF 6 billions, out of FF 400 billions for the european market, ie less than
1.5 %. This figure is higher in Nederland (14 %), Denmark ( 11%) and UK
(7%). Companies try to lower parallel imports by adapting products to each
individual country : different brand name, different presentation,...),
and by exerting pressures on sister companies.
Jerome Dumoulin
Institut de Recherche Economique sur la Production et le Developpement
Universite Pierre Mendes France
BP 47
F-38040 GRENOBLE Cedex 09
tel 33 4 76 82 54 50
fax 33 4 76 82 59 89
http://www.upmf-grenoble.fr/irepd
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.